Galmed Pharmaceuticals Ltd (GLMD)

NASDAQ

$0.52

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. The company is headquartered in Tel Aviv, Israel.

Website: https://galmedpharma.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Hold

Target: $12 (+2212.14%)

Market Cap

$3.38M

P/B Ratio

0.28

Beta (5Y)

1.87

Price Chart

Adjust inflation

Log

Valuation

Market Cap$3.38M

P/S61.38

P/B0.28

Profitability

EBITDA-$10M

EPS-$1.57

Growth & Risk

EPS 5Y CAGR-33.02%

Beta (5Y)1.87

Sharpe Ratio-0.96